Benchmark: Reiterates Select Medical Hldgs (SEM.US) rating and adjusted from buy to buy rating, target price is $39.00.
Zhitong FinanceApr 12 21:41
Select Medical Hldgs Analyst Ratings
BenzingaApr 12 21:35
Deutsche Bank Adjusts Price Target on Select Medical to $40 From $37, Maintains Buy Rating
MT NewswiresJan 6 00:25
UBS Initiates Coverage On Select Medical Hldgs With Neutral Rating, Announces Price Target of $26
BenzingaNov 30, 2023 21:41
Select Medical Hldgs Analyst Ratings
BenzingaNov 30, 2023 21:38
Benchmark Reiterates Buy on Select Medical Hldgs, Maintains $39 Price Target
BenzingaNov 9, 2023 02:23
Select Medical Hldgs Analyst Ratings
BenzingaNov 9, 2023 02:22
RBC Cuts Price Target on Select Medical Holdings to $30 From $38, Keeps Outperform Rating
MT NewswiresNov 6, 2023 21:06
Credit Suisse Maintains Neutral on Select Medical Hldgs, Raises Price Target to $32
BenzingaAug 7, 2023 20:02
Select Medical Hldgs Analyst Ratings
BenzingaAug 7, 2023 20:02
RBC Capital Reiterates Outperform on Select Medical Hldgs, Maintains $38 Price Target
BenzingaJul 20, 2023 22:05
Select Medical Hldgs Analyst Ratings
BenzingaJul 20, 2023 22:04
RBC Lifts Price Target on Select Medical Holdings to $38 From $32, Cites Improved Labor Costs, Industry Multiple Expansion; Outperform Kept
MT NewswiresMay 8, 2023 19:48
Credit Suisse Reiterates Neutral on Select Medical Hldgs, Maintains $29 Price Target
BenzingaMay 8, 2023 19:45
RBC Capital Keeps Their Buy Rating on Select Medical (SEM)
TipRanksFeb 28, 2023 09:50
Credit Suisse Maintains Neutral on Select Medical Hldgs, Raises Price Target to $29
BenzingaFeb 27, 2023 21:00
Select Medical Hldgs Analyst Ratings
Benzinga Analyst RatingsNov 7, 2022 23:02
RBC Capital Maintains Outperform on Select Medical Hldgs, Lowers Price Target to $32
Benzinga Real-time NewsNov 7, 2022 23:01
RBC Cuts Price Target on Select Medical Holdings to $32 From $36, Keeps Outperform Rating
MT NewswiresNov 7, 2022 22:35
No Data
No Data